$14.0M
The Oxford medical technology company secured backing from investors including Mercia and IQ Capital to scale its diagnostic software.
O
Optellum
Optellum develops artificial intelligence software to diagnose early-stage lung cancer.
Oxford, UK—Founded 2016
$14.0MTotal raised
An Oxford-based medical technology company providing an artificial intelligence platform for the early diagnosis and management of lung cancer.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Optellum's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
VP
Vaclav Potesil
Founder
Vaclav founded Optellum and serves as chief product and strategy officer, having previously led the company as chief executive officer. He brings artificial intelligence and medical technology experience, alongside mentoring at the Texas Medical Center Innovation Accelerator.
LinkedIn